- Home
- JANX vs RAMP Comparison
JANX vs RAMP Comparison
Compare JANX & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- RAMP
- Stock Information
- Founded
- JANX 2017
- RAMP 2018
- Country
- JANX United States
- RAMP United States
- Employees
- JANX N/A
- RAMP N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- RAMP EDP Services
- Sector
- JANX Health Care
- RAMP Technology
- Exchange
- JANX Nasdaq
- RAMP Nasdaq
- Market Cap
- JANX 1.5B
- RAMP 1.8B
- IPO Year
- JANX 2021
- RAMP 1987
- Fundamental
- Price
- JANX $25.96
- RAMP $32.88
- Analyst Decision
- JANX Strong Buy
- RAMP Buy
- Analyst Count
- JANX 8
- RAMP 8
- Target Price
- JANX $90.63
- RAMP $39.38
- AVG Volume (30 Days)
- JANX 839.1K
- RAMP 382.8K
- Earning Date
- JANX 08-06-2025
- RAMP 08-06-2025
- Dividend Yield
- JANX N/A
- RAMP N/A
- EPS Growth
- JANX N/A
- RAMP N/A
- EPS
- JANX N/A
- RAMP N/A
- Revenue
- JANX $9,336,000.00
- RAMP $745,580,000.00
- Revenue This Year
- JANX N/A
- RAMP $9.94
- Revenue Next Year
- JANX $1,470.82
- RAMP $9.35
- P/E Ratio
- JANX N/A
- RAMP N/A
- Revenue Growth
- JANX 28.12
- RAMP 13.03
- 52 Week Low
- JANX $22.48
- RAMP $21.45
- 52 Week High
- JANX $71.71
- RAMP $36.08
- Technical
- Relative Strength Index (RSI)
- JANX 53.36
- RAMP 52.48
- Support Level
- JANX $25.81
- RAMP $32.23
- Resistance Level
- JANX $27.31
- RAMP $33.62
- Average True Range (ATR)
- JANX 1.30
- RAMP 0.61
- MACD
- JANX 0.08
- RAMP -0.11
- Stochastic Oscillator
- JANX 45.02
- RAMP 34.41
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About RAMP LiveRamp Holdings Inc.
LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.